Related Experiment Video
Updated: Aug 27, 2025
Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Crystallization of Human Monoamine Oxidase B
Claudia Binda1, Dale E Edmondson2, Andrea Mattevi3
1Department of Biology and Biotechnology, University of Pavia, Pavia, Italy. claudia.binda@unipv.it.
Researchers developed a method to crystallize monoamine oxidase B (MAO B), crucial for neurotransmitter balance. This breakthrough aids drug design for neurological disorders like Parkinson's disease.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Monoamine oxidases A and B (MAO A and B) are key regulators of neurotransmitter balance in the central nervous system and periphery.
- MAO A and B are validated drug targets for treating depression and Parkinson's disease.
Purpose of the Study:
- To elucidate the crystal structure of human MAO B to guide drug design.
- To develop a reproducible protocol for obtaining MAO B crystals.
Main Methods:
- Development of a heterologous expression system for MAO B in Pichia pastoris.
- Optimization of detergent, buffer, and precipitant conditions for MAO B crystallization.
- Determination of the first crystal structure of human MAO B.
Main Results:
- The first crystal structure of human MAO B was determined in 2002.
- A detailed protocol for reproducible MAO B crystallization was established.
Conclusions:
- The established protocol enables consistent MAO B crystallization, facilitating structure-based drug design.
- Understanding MAO B structure is vital for developing targeted therapeutics for neurological conditions.
More Related Videos
10:21Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins
Published on: June 20, 2019
11:27X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020